PerpEquities

Zoetis Inc. (ZTS) balance sheet

NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · 14,500 employees · CEO Kristin C. Peck

Price
$82.11 -7.95%
Market cap
$33.9B
Enterprise value
$32.8B
Last report
Q3 '26 filed 2026-11-05
Next report
2027-02-11 EPS est. $1.29

At the end of Q3 '26 Zoetis Inc. (ZTS) held $1.53B in cash and short-term investments against $188M of debt incl. leases. Total assets $15.1B, total liabilities $11.8B, shareholders' equity $3.3B.

Balance sheet

Balance sheetTrendQ4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Assets
Cash & equivalents$2.04B$1.97B$1.57B$1.71B$1.99B$1.72B$1.44B$2.08B$2.31B$1.94B$1.48B$1.33B
Short-term investments$0$0$0$0$0$0$0$0$0$0$200M$200M
Receivables$1.3B$1.29B$1.38B$1.41B$1.32B$1.36B$1.54B$1.54B$1.59B$1.51B$1.57B$1.69B
Inventory$2.56B$2.65B$2.45B$2.42B$2.31B$2.37B$2.44B$2.47B$2.43B$2.55B$2.57B$2.54B
Other current assets$436M$442M$794M$745M$379M$430M$509M$493M$438M$477M$535M$532M
Current assets$6.34B$6.36B$6.2B$6.28B$5.99B$5.88B$5.92B$6.58B$6.77B$6.47B$6.36B$6.29B
Property, plant & equipment (net)$3.43B$3.48B$3.42B$3.52B$3.61B$3.66B$3.84B$3.89B$3.97B$4B$4.03B$4.05B
Long-term investments$0$0$0$0$30M$0$0$1M$0$0$0$0
Goodwill$2.76B$2.76B$2.74B$2.74B$2.72B$2.72B$2.76B$2.76B$2.77B$2.78B$2.77B$2.89B
Intangible assets$1.34B$1.3B$1.23B$1.19B$1.13B$1.08B$1.08B$1.04B$998M$959M$918M$850M
Deferred tax assets$206M$232M$366M$409M$540M$530M$617M$587M$637M$591M$617M$608M
Other non-current assets$206M$227M$210M$215M$250M$232M$267M$292M$328M$351M$384M$398M
Non-current assets$7.94B$7.99B$7.96B$8.08B$8.25B$8.22B$8.56B$8.58B$8.7B$8.68B$8.72B$8.8B
Total assets$14.3B$14.3B$14.2B$14.4B$14.2B$14.1B$14.5B$15.2B$15.5B$15.2B$15.1B$15.1B
Liabilities
Accounts payable$411M$405M$420M$404M$433M$420M$508M$410M$487M$507M$452M$419M
Accrued expenses$683M$691M$704M$725M$746M$772M$770M$337M$410M$751M$0$0
Short-term debt$3M$24M$0$0$1.35B$1.35B$1.35B$0$53M$0$0$0
Taxes payable$110M$230M$82M$97M$93M$211M$93M$152M$147M$211M$138M$201M
Deferred revenue$0$0$0$0$0$0$0$12M$11M$0$0$0
Other current liabilities$484M$361M$394M$476M$566M$408M$423M$896M$1.13B$360M$1.47B$2.68B
Current liabilities$1.89B$1.91B$1.8B$1.7B$3.41B$3.39B$3.37B$1.81B$2.24B$2.05B$2.06B$2.68B
Long-term debt$6.56B$6.56B$6.56B$6.57B$5.22B$5.23B$5.23B$7.07B$9.24B$9.05B$9.05B$188M
Lease obligations (non-current)$188M$184M$181M$181M$174M$173M$210M$204M$202M$193M$190M$0
Deferred revenue (non-current)$0$0$0$0$0$0$0$0$17M$0$21M$0
Deferred tax liabilities$146M$136M$175M$172M$167M$161M$156M$147M$139M$130M$122M$104M
Other non-current liabilities$508M$505M$489M$494M$480M$497M$539M$534M$305M$500M$487M$8.81B
Non-current liabilities$7.41B$7.39B$7.41B$7.42B$6.06B$6.06B$6.14B$7.95B$9.9B$9.87B$9.87B$9.1B
Total liabilities$9.3B$9.3B$9.21B$9.12B$9.47B$9.44B$9.5B$9.76B$12.1B$11.9B$11.9B$11.8B
Equity
Common stock & paid-in capital$5M$5M$5M$5M$5M$5M$5M$5M$5M$5M$5M$5M
Retained earnings$10.3B$10.7B$11.1B$11.8B$12B$12.4B$12.9B$13.6B$13.7B$14.2B$14.7B$15.2B
Accumulated other comprehensive income-$839M-$841M-$845M-$851M-$940M-$1.02B-$877M-$818M-$834M-$772M-$796M-$755M
Shareholders' equity$5B$5.06B$4.97B$5.23B$4.77B$4.66B$4.98B$5.4B$3.33B$3.23B$3.15B$3.3B
Debt
Total debt (incl. leases)$6.76B$6.77B$6.74B$6.76B$6.74B$6.75B$6.79B$7.27B$9.49B$9.24B$9.24B$188M
Net debt (debt - cash)$4.72B$4.8B$5.17B$5.05B$4.76B$5.03B$5.36B$5.19B$7.18B$7.3B$7.76B-$1.15B

Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30

Data as of 2026-11-06